Shed vs bmiMD: coaching and name-brand options vs lower long-term cost
The primary comparison when searching Shed vs bmiMD is whether you value integrated coaching and name-brand options or lower long-term monthly cost for compounded tirzepatide. Early verdict: pick Shed if you want name-brand GLP-1 options plus continuous coaching; choose bmiMD if you want lower long-term monthly pricing on compounded tirzepatide and free subscription shipping.
Start Shed 2-minute assessment
How they differ at a glance: coaching and medication type, pricing model, and shipping
This comparison focuses on the most distinctive supported differences between Shed and bmiMD: (1) name-brand and compounded options plus coaching at Shed versus compounded-only tirzepatide at bmiMD, (2) pricing structure and multi-month discounts, and (3) shipping and clinician access features. Each point below uses only the supplied source facts and qualifiers.
1. Medication options and regulatory notes
Shed offers both FDA-approved name-brand GLP-1 medications and compounded alternatives on one platform. Compounded medications at Shed are noted as not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription. bmiMD focuses on compounded tirzepatide specifically. bmiMD also includes the regulatory qualifier that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
2. Integrated coaching versus clinician access
Shed integrates continuous coaching into treatment so medication is paired with behavioral support rather than a prescription-only model. The source frames this as a differentiator for patients who want more than a script. bmiMD highlights 24/7 clinician access and online refills, emphasizing clinician availability and subscription delivery rather than bundled coaching.
3. Pricing structure and multi-month savings
Shed lists compounded semaglutide injections starting at $199/month and compounded tirzepatide starting at $299/month and promotes 10% off your first month for new patients. Standalone pricing beyond those starting points is provided as personalized quotes after intake. bmiMD advertises multiple billing options with explicit monthly equivalents: $179 month-to-month; $159 for a three-month plan; $149 for a six-month plan; and $139 for a 12-month plan, with the lowest price requiring a longer commitment. bmiMD says the lowest price is a 12-month plan and notes total prepaid charge should be confirmed.
Comparison table: Shed vs bmiMD
| Criteria | Shed | bmiMD |
|---|---|---|
| Medication types | Name-brand and compounded GLP-1 options | Compounded tirzepatide (GLP-1/GIP) |
| Regulatory note | Compounded meds are not FDA-approved | Compounded meds are not FDA-approved |
| Pricing example | Compounded semaglutide starting at $199/month; compounded tirzepatide starting at $299/month; 10% off first month | $179 month-to-month; $159 3-month; $149 6-month; $139 12-month |
| Coaching or clinician support | Continuous coaching integrated into treatment | 24/7 clinician access and online refills |
| Shipping and delivery | Medication shipped after clinician review; details personalized | Free subscription shipping on every order |
4. Enrollment, approvals, and refunds
Shed uses a 2-minute online assessment to check eligibility and notes a licensed clinician confirms treatment before a prescription is issued. Shed also mentions a weight-loss guarantee with full terms in the Terms and Conditions. bmiMD promotes a 100% risk free refundable statement if not eligible for the program and encourages confirming eligibility, total cost, renewal terms and state availability before enrollment.
See bmiMD plan options and shipping
5. Who each provider appears best for
The sources frame Shed as best for patients who want more than a prescription and value integrated coaching plus a choice of name-brand or compounded medications. bmiMD is framed as best for people who prioritize lower long-term monthly equivalents on compounded tirzepatide with free subscription shipping and clear multi-month pricing tiers, provided they confirm commitments and total prepaid charges.
Explore Shed medication and coaching
Final comparison and how to choose
In a direct comparison of Shed vs bmiMD, the deciding factors are whether you need name-brand options and continuous coaching or whether you want lower long-term monthly pricing on compounded tirzepatide with free subscription shipping. Both providers note that compounded medications are not FDA-approved and that treatment is available only when a licensed clinician determines it is medically appropriate.
Choose Shed if…
you want access to FDA-approved name-brand GLP-1 medications alongside compounded alternatives, integrated continuous coaching as part of treatment, a 2-minute approval assessment, and an introductory 10% off your first month. Shed is presented as strongest for patients seeking behavioral support in addition to medication.
Choose bmiMD if…
you are focused on compounded tirzepatide with clear multi-month pricing that lowers the monthly equivalent to as low as $139 on a 12-month plan, you want free subscription shipping, and you value 24/7 clinician access and online refill delivery. bmiMD is presented as best for people who confirm eligibility, total cost, renewal terms and state availability before enrolling.